Trials / Conditions / Ovarian Cancer Metastatic Recurrent
Ovarian Cancer Metastatic Recurrent
5 registered clinical trials studyying Ovarian Cancer Metastatic Recurrent — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expres NCT07311577 | Jiangsu Cancer Institute & Hospital | Phase 2 |
| Not Yet Recruiting | Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy NCT07340164 | Yonsei University | Phase 2 |
| Recruiting | Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants W NCT07444814 | Whitehawk Therapeutics, Inc. | Phase 1 |
| Recruiting | Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progre NCT06839144 | Tel-Aviv Sourasky Medical Center | Phase 2 |
| Completed | Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cance NCT00484432 | AGC Biologics S.p.A. | Phase 2 |